Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
Abstract Background The results of leflunomide (LEF) in patients with IgA nephropathy (IgAN) were inconsistent. Methods A total of 149 kidney biopsy-confirmed IgAN patients with an estimated glomerular filtration rate (eGFR) ≥ 50 ml/min/1.73 m2 and protein excretion levels ≥0.75 g/d were enrolled, w...
Guardado en:
Autores principales: | Yebei Li, Yi Xiong, Tianlun Huang, Xin Liu, Gaosi Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ac669d511744fb3ab929694e5bdec18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
<i>NR3C1</i> Glucocorticoid Receptor Gene Polymorphisms Are Associated with Membranous and IgA Nephropathies
por: Michał Pac, et al.
Publicado: (2021) -
Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis
por: Shi-Yao Wei, et al.
Publicado: (2021) -
The prognostic role of heart rate recovery after exercise and metabolic syndrome in IgA nephropathy
por: Balázs Sági, et al.
Publicado: (2021) -
Potential Radioprotective Effect of AT1 Receptor Antagonists Against Morphological and Ultrastructural Changes in the Testes Induced by Ionizing Radiation
por: Schwarz,Franciele Cristina, et al.
Publicado: (2017) -
IgA Nephropathy Secondary to Ipilimumab Use
por: Sean C. Dougherty, et al.
Publicado: (2021)